4//SEC Filing
EMANUELE ROBERT MARTIN 4
Accession 0001209191-13-003698
CIK 0001160308other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 6:24 PM ET
Size
5.4 KB
Accession
0001209191-13-003698
Insider Transaction Report
Form 4
EMANUELE ROBERT MARTIN
Senior VP, Development
Transactions
- Other
Common Stock
2012-12-13$0.00/sh−305,608$306→ 242,055 total
Footnotes (2)
- [F1]This disposition was not an open market sale by the reporting person (Dr. Emanuele). This disposition was to the issuer (ADVENTRX Pharmaceuticals) as a result of the issuer's exercise of its option to repurchase the shares, which was related to the timing of and planned number of subjects in the issuer's phase 3 study of ANX-188, all as contemplated in the Agreement and Plan of Merger, dated February 12, 2011, by and among the issuer, SRX Acquisition Corporation, SynthRx, Inc. and the reporting person, as Stockholders' Agent (the "Merger Agreement").
- [F2]The repurchase price was fixed by the terms of the Merger Agreement and does not reflect the market price of the issuer's common stock.
Documents
Issuer
ADVENTRX PHARMACEUTICALS INC
CIK 0001160308
Entity typeother
Related Parties
1- filerCIK 0001184991
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 6:24 PM ET
- Size
- 5.4 KB